Ex vivo peripheral blood mononuclear cell response to R848 in children after supplementation with the probiotic Lactobacillus acidophilus NCFM/Bifidobacterium lactis Bi-07
Open Access
- 24 February 2021
- journal article
- research article
- Published by Brill in Beneficial Microbes
- Vol. 12 (1), 85-93
- https://doi.org/10.3920/bm2020.0068
Abstract
Several studies have demonstrated a decrease in upper respiratory infection (URI) frequency and severity in subjects taking probiotic supplements. We hypothesised beneficial effects of probiotics on viral URI in children are due to modulation of inflammatory innate immune responses. We tested this hypothesis, providing children with a probiotic combination of Lactobacillus acidophilus/Bidfidobacterium animalis ssp. lactis Bi-07 (NCFM/Bi-07) and measuring levels of cytokines in response to stimulation of peripheral blood mononuclear cells (PBMCs) to toll-like receptor (TLR) 7/8 agonist resiquimod (R848). In this open label study, 21 (2 dropouts) children received probiotic containing 5×109 cfu each of NCFM/(Bi-07) daily for 30 days. Whole blood was taken from each subject at study entry and 30 days for culture of PBMCs. PBMCs stimulated with resiquimod (R848) or unstimulated were incubated and a panel of immune markers was measured. There was a significant decrease in the net (stimulated-null) level of myeloid progenitor inhibitory factor 1 (MPIF-1) (mean decrease 0.1 ng/ml, 95% confidence interval 0.01-0.24, P=0.032) following probiotic supplementation. The change in immune marker levels after supplementation, when analysed together with respect to expected inflammatory/anti-inflammatory effects, was increased for interleukin (IL)-10 and decreased for MPIF-1, IL-8, interferon gamma induced protein 10, macrophage inflammatory protein 3 alpha (MIP-3α) and E-selectin (P=0.01). Adverse events were mild. In conclusion, supplementation with this probiotic combination was safe and resulted in significant modulation of PBMC limited immune response to TLR7/8 agonist R848 and in levels of MPIF-1 and MIP-3α. The anti-inflammatory effect may be one mechanism by which probiotics modulate the immune system however further study is needed.Keywords
This publication has 52 references indexed in Scilit:
- The role of the lung microbiota and the gut-lung axis in respiratory infectious diseasesCellular Microbiology, 2018
- Human Neutrophils Produce CCL23 in Response to Various TLR-Agonists and TNFαFrontiers in Cellular and Infection Microbiology, 2017
- Effects of probiotic supplementation over 5 months on routine haematology and clinical chemistry measures in healthy active adultsEuropean Journal of Clinical Nutrition, 2014
- Functional Analysis via Standardized Whole-Blood Stimulation Systems Defines the Boundaries of a Healthy Immune Response to Complex StimuliImmunity, 2014
- The type I interferon response during viral infections: a “SWOT” analysisReviews in Medical Virology, 2011
- Regulation of the IL-10/IL-12 axis in human dendritic cells with probiotic bacteriaFEMS Immunology & Medical Microbiology, 2011
- Nasal Secretion Concentrations of IL-5, IL-6, and IL-10 in Children With and Without Upper Respiratory Tract VirusesJAMA Otolaryngology–Head & Neck Surgery, 2010
- Mucosal Immunity: Induction, Dissemination, and Effector FunctionsScandinavian Journal of Immunology, 2009
- Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteriaWorld Journal of Gastroenterology, 2007
- The Economic Burden of Non–Influenza-Related Viral Respiratory Tract Infection in the United StatesArchives of Internal Medicine, 2003